Back89bio Overview

89bio Other Current Assets

Latest other current assets for ETNB: $40M.

Get informed when a big investor buys or sells

+ Follow
Other Current Assets
$40.36M
16.74% YoYΔ $-8.11M vs prior year quarter

Peer average / median

Loading

89bio Other Current Assets History

Loading

89bio vs. peers: Other Current Assets Comparison

Loading

89bio Other Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

89bio (ETNB) FAQ

As of the most recent data (June 2025), ETNB shows a other current assets of $40M. That compares with $48M in the prior-year period — down 16.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ETNB's other current assets is now $40M (was $48M) — a 16.7% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether 89bio is outperforming or lagging.

Tracking ETNB's other current assets over time shows whether 89bio is scaling, shrinking, or reshaping that part of the business. The current reading is $40M That compares with $48M in the prior-year period — down 16.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current assets page, Stockcircle has 89bio's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current assets (currently $40M) with ownership activity and broader fundamentals.

89bio's other current assets is $40M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.